Biosafety Testing For Biopharmaceuticals

Bioanalytical & Data

Information

Testing for safety/identity/residual impurities from: - Cell banks - Control cells - Virus seed/bank - Viral bulk harvest - Drug Substance - Raw materials (viral safety) Assays & Studies: • qPCR assays • DNA sequencing (transgenes, vectors, plasmids) • Identity • Electron microscopy studies • Adventitious agent detection • Retrovirus detection • Residual cell culture impurities • Genetic Stability • Microbial contaminants • Biosafety consultancy services

SGS Health ScienceSGS is the world’s leading inspection, verification, testing and certification company. With more than 89,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world. The Health Science division serves pharmaceutical, biopharmaceutical, and medical device companies along the entire drug development pathway. With over 40 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products. www.sgs.com/CRO SGS Health Science | LinkedIn

Biosafety Testing For Biopharmaceuticals

Information

Log in